These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16580595)

  • 1. Joseph Miletich talks about big Pharma, biotech and the future of Amgen. Interview by Steve Carney.
    Miletich JP
    Drug Discov Today; 2006 Mar; 11(5-6):188-90. PubMed ID: 16580595
    [No Abstract]   [Full Text] [Related]  

  • 2. Fates intertwined.
    Cooper GJ
    Nat Biotechnol; 2006 Mar; 24(3):252-4. PubMed ID: 16525372
    [No Abstract]   [Full Text] [Related]  

  • 3. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 4. South Korean biotechnology--a rising industrial and scientific powerhouse.
    Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
    [No Abstract]   [Full Text] [Related]  

  • 5. The emergence of Egyptian biotechnology from generics.
    Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
    [No Abstract]   [Full Text] [Related]  

  • 6. Italian biotech too reliant on big pharma.
    Meldolesi A
    Nat Biotechnol; 2004 Aug; 22(8):1047. PubMed ID: 15309759
    [No Abstract]   [Full Text] [Related]  

  • 7. Chris Ashton talks about his career and the recent merger of Argenta Discovery and Etiologics. Interview by Steve Carney.
    Ashton C
    Drug Discov Today; 2005 Jan; 10(2):82-5. PubMed ID: 15718154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conclusions: promoting biotechnology innovation in developing countries.
    Thorsteinsdóttir H; Quach U; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl(Suppl 12):DC48-52. PubMed ID: 15583685
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 11. South Africa--blazing a trail for African biotechnology.
    Motari M; Quach U; Thorsteinsdóttir H; Martin DK; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC37-41. PubMed ID: 15583683
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 13. Cuba--innovation through synergy.
    Thorsteinsdóttir H; Sáenz TW; Quach U; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC19-24. PubMed ID: 15583679
    [No Abstract]   [Full Text] [Related]  

  • 14. Newsmaker interview. Defying skeptics, Richard Scheller thinks Genentech will thrive. Interview by Greg Miller.
    Scheller R
    Science; 2009 May; 324(5927):583. PubMed ID: 19407174
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech boot camp.
    Ledford H
    Nature; 2015 Mar; 519(7544):402-5. PubMed ID: 25810186
    [No Abstract]   [Full Text] [Related]  

  • 16. The scientific muscle of Brazil's health biotechnology.
    Ferrer M; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC8-12. PubMed ID: 15583686
    [No Abstract]   [Full Text] [Related]  

  • 17. When times get tough.
    Jong S
    Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
    [No Abstract]   [Full Text] [Related]  

  • 18. Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development.
    Lee VH
    Drug Discov Today; 2005 Nov; 10(21):1411-4. PubMed ID: 16243258
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.